HIV Protease Substrate III-B (Native Sequence)

HIV Protease Substrate III-B (Native Sequence) mirrors natural cleavage motifs recognized by HIV protease. The peptide architecture supports analysis of catalytic efficiency under controlled conditions. Its residue pattern allows investigation of substrate specificity and mechanistic preferences. Researchers use it in inhibitor evaluation, kinetic assays, and enzymatic profiling.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: HB00156

CAS No:179912-80-2

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C51H90N18O14S
M.W/Mr.
1211.46
Sequence
Three-Letter Code: H-His-Lys-Ala-Arg-Val-Leu-Ala-Glu-Ala-Met-Ser-NH

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Synthesis ServicesPeptide CDMOPeptide Analysis ServicesPeptide Nucleic Acids SynthesiscGMP Peptide ServiceEpitope Mapping ServicesCustom Conjugation ServicePeptide Modification Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers